Brainsway Competitors

Stocks . Israel . 
Stock . Brainsway
BWAY Stock  ILA 1,746  43.00  2.52%   
Brainsway competes with Intercure, Sofwave Medical, Epitomee Medical, Bio View, and Elbit Imaging; as well as few others. The company operates under Healthcare sector and is part of Medical Devices industry. Analyzing Brainsway competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Brainsway to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Brainsway Correlation with its peers.
For information on how to trade Brainsway Stock refer to our How to Trade Brainsway Stock guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Brainsway competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
1,7431,7461,749
Details
Intrinsic
Valuation
LowRealHigh
1,4461,4491,921
Details

Brainsway Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Brainsway and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Brainsway and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Brainsway does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
HUMX
+ 0.88
INCR
INSL
+ 0.55
INCR
EMITF
+ 0.55
EPIT
HUMX
+ 0.47
INSL
INSL
+ 0.46
SOFW
ENDY
+ 0.39
EMITF
  
High negative correlations   
HUMX
- 0.8
EMITF
EMITF
- 0.78
INCR
HUMX
- 0.67
ENDY
INSL
- 0.66
EMITF
ENDY
- 0.57
INCR
EPIT
- 0.56
INCR

Risk-Adjusted Indicators

There is a big difference between Brainsway Stock performing well and Brainsway Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Brainsway's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Brainsway Competitive Analysis

The better you understand Brainsway competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Brainsway's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Brainsway's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BWAY INCR SOFW EPIT BIOV EMITF INSL ENDY HUMX
 2.52 
 1,746 
Brainsway
 0.32 
 615.00 
Intercure
 2.02 
 1,503 
Sofwave
 1.10 
 947.50 
Epitomee
 0.35 
 28.90 
Bio
 3.11 
 600.00 
Elbit
 9.64 
 196.00 
Insuline
 0.34 
 295.00 
Endymed
 0.69 
 29.10 
Human
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Not too volatile
Market Performance
(90 Days Performance)
Insignificant
Very Weak
Very Weak
Insignificant
Insignificant
Good
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Low
Below Average
Low
Low
Below Average
Below Average
Low
Above Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
9.26
0.31
N/A
N/A
2.14
0.29
0.98
2.58
16.84
Net Asset
75.73 M
686.32 M
N/A
N/A
40.02 M
72.27 M
1.58 M
19.6 M
N/A
Profit Margin
-0.37
0.0915
-0.61
N/A
0.0385
N/A
N/A
0.14
N/A
EBITDA
(3.31 M)
31.18 M
(15.14 M)
N/A
4.72 M
(20.43 M)
(6.82 M)
3.2 M
(45.95 M)
Operating Margin
-0.29
0.18
-0.62
N/A
0.0204
-2.36
N/A
0.0556
-14.93
Current Valuation
(85.93 M)
688.06 M
174.37 M
339.18 M
35.4 M
335.88 M
N/A
1.85 M
(47.61 M)
Price To Book
0.65
1.43
2.19
3.48
1.72
0.73
N/A
0.7
0.27
Retained Earnings
N/A
(35 M)
N/A
N/A
(29 M)
(267 M)
(158 M)
(12 M)
N/A
Current Asset
N/A
1000 K
N/A
N/A
26 M
249 M
8 M
9 M
N/A
Beta
0.2
-0.22
N/A
N/A
0.53
0.89
1.79
-0.0864
1.26
Number Of Employees
118
350
92
6
35
4
26
41
72
Shares Outstanding
33.08 M
45.57 M
34.15 M
29.58 M
13.75 M
9.19 M
N/A
13.76 M
26.76 M
Cash Flow From Operations
884 K
25.02 M
N/A
N/A
3.25 M
(3.38 M)
(7.68 M)
4.63 M
(27.26 M)
Annual Yield
N/A
N/A
N/A
N/A
N/A
0.0948
N/A
N/A
N/A
Total Debt
672 K
11.95 M
N/A
N/A
2.57 M
280.59 M
N/A
463 K
7.55 M
Return On Equity
-0.2
0.0736
-0.35
N/A
0.0399
-0.25
N/A
0.21
-0.5
Z Score
N/A
27.6
N/A
N/A
12.0
-9.0
N/A
46.6
1.8
Return On Asset
-0.0751
0.0538
-0.18
N/A
0.0091
-0.0522
N/A
0.0385
-0.27
Book Value Per Share
1.46
10.75
1.12
N/A
2.0
7.72
-0.16
1.04
2.67
Current Liabilities
N/A
1000 K
N/A
N/A
8 M
595 M
9 M
4 M
N/A
Total Asset
75.73 M
686.32 M
N/A
N/A
40.02 M
72.27 M
1.58 M
19.6 M
N/A
Debt To Equity
0.034
64.9
N/A
N/A
11.8
N/A
N/A
7.1
0.05
Target Price
14.0
40.23
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
0.5
N/A
N/A
N/A
Shares Owned By Institutions
1.11
11.6
22.84
20.28
N/A
6.25
N/A
N/A
9.62
Market Capitalization
116.06 M
551.89 M
392.36 M
318.32 M
53.86 M
51.49 M
36.33 M
35.42 M
28.63 M
Price To Earning
N/A
590.59
N/A
N/A
N/A
-40.77
-40.77
N/A
N/A
Price To Sales
3.76
1.87
10.41
N/A
1.71
16.72
N/A
1.52
6.2
Net Income
(6.46 M)
4.69 M
N/A
N/A
2.18 M
(20.5 M)
(7.01 M)
5.16 M
(28.54 M)
Earnings Per Share
-0.22
0.74
-0.29
N/A
0.09
-2.24
-30.78
0.74
-2.01
Shares Owned By Insiders
19.83
37.64
53.24
56.83
51.58
28.9
N/A
58.11
55.22
Revenue
29.66 M
219.68 M
25.33 M
N/A
30.51 M
N/A
40 K
21.78 M
3.12 M
Working Capital
N/A
N/A
N/A
N/A
18 M
(346 M)
(1000 K)
5 M
N/A
Cash And Equivalents
55.87 M
3.66 M
N/A
N/A
17.67 M
42.11 M
1.15 M
5.02 M
148.31 M
Cash Per Share
1.73
0.04
N/A
N/A
1.24
4.58
2.86
0.39
5.56
Gross Profit
24.35 M
102.56 M
16.21 M
N/A
17.59 M
N/A
N/A
10.06 M
1.62 M
Day Typical Price
1720.0
612.67
1503.33
960.8
28.47
596.0
197.57
294.0
28.77
Accumulation Distribution
0.0447
0.0306
0.0398
0.0593
0.0717
0.02
0.0234
0.0102
0.0544
Market Facilitation Index
78.0
19.0
61.0
59.1
2.1
12.0
4.7
3.0
1.6
Daily Balance Of Power
0.5513
(0.11)
(0.51)
(0.18)
0.0476
1.508333
(4.45)
0.3333
0.125
Period Momentum Indicator
43.0
(2.00)
(31.00)
(10.50)
0.1
18.1
(20.90)
1.0
0.2
Rate Of Daily Change
1.03
1.0
0.98
0.99
1.0
1.03
0.9
1.0
1.01
Day Median Price
1707.0
611.5
1503.5
967.45
28.25
594.0
198.35
293.5
28.6
Price Action Indicator
60.5
2.5
(16.00)
(25.20)
0.7
15.05
(12.80)
2.0
0.6
Coefficient Of Variation
919.91
(1,586)
(1,418)
839.16
2891.74
385.15
(2,505)
2213.33
(748.01)
Mean Deviation
2.03
2.86
1.79
10.35
3.03
2.16
2.96
2.58
3.64
Jensen Alpha
0.297
(0.27)
(0.19)
3.77
0.1299
0.7601
(0.22)
0.261
(0.69)
Total Risk Alpha
0.2164
(0.39)
(0.28)
2.89
0.0176
0.6638
(0.39)
0.0926
(0.82)
Sortino Ratio
0.1118
N/A
N/A
0.6487
0.0262
0.3053
N/A
0.0686
N/A
Downside Variance
5.93
N/A
N/A
33.52
17.4
5.6
N/A
11.73
N/A
Standard Deviation
2.8
4.22
2.73
31.79
4.09
2.91
5.58
5.91
5.04
Kurtosis
0.5491
11.15
2.09
58.07
1.47
1.13
2.89
39.81
0.4316
Potential Upside
5.95
5.11
5.16
24.42
6.69
6.12
10.25
4.11
7.38
Treynor Ratio
(2.47)
1.11
0.3805
7.5
1.83
(1.07)
0.512
(1.49)
(2.14)
Maximum Drawdown
12.44
25.45
14.75
273.98
22.33
16.02
33.39
48.06
22.84
Variance
7.84
17.84
7.43
1010.51
16.74
8.45
31.17
34.98
25.39
Market Risk Adjusted Performance
(2.46)
1.12
0.3905
7.51
1.84
(1.06)
0.522
(1.48)
(2.13)
Risk Adjusted Performance
0.0938
(0.04)
(0.05)
0.1047
0.0356
0.2142
(0.02)
0.0447
(0.1)
Skewness
0.5136
2.25
(0.52)
7.41
(0.04)
0.6834
(0.37)
5.55
(0.40)
Semi Deviation
2.19
N/A
N/A
4.4
3.72
1.75
N/A
2.71
N/A
Information Ratio
0.0972
(0.07)
(0.08)
0.1182
0.0267
0.2486
(0.05)
0.0397
(0.14)
Value At Risk
(3.88)
(5.48)
(5.18)
(9.13)
(5.24)
(3.85)
(10.36)
(5.83)
(10.39)
Expected Short fall
(2.33)
N/A
N/A
(16.44)
(3.59)
(2.80)
N/A
(3.96)
N/A
Downside Deviation
2.44
N/A
N/A
5.79
4.17
2.37
N/A
3.42
N/A
Semi Variance
4.77
N/A
N/A
19.4
13.88
3.08
N/A
7.36
N/A

Brainsway Competition Performance Charts

Five steps to successful analysis of Brainsway Competition

Brainsway's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Brainsway in relation to its competition. Brainsway's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Brainsway in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Brainsway's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Brainsway, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Brainsway position

In addition to having Brainsway in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Marijuana Thematic Idea Now

Marijuana
Marijuana Theme
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Brainsway Stock

When determining whether Brainsway offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainsway's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:
How To Invest In Brainsway
Details
Is Brainsway Stock a good investment?
Details
What is Brainsway's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out Brainsway Correlation with its peers.
For information on how to trade Brainsway Stock refer to our How to Trade Brainsway Stock guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Brainsway's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainsway is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainsway's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY